During the past decade, Central California ENT conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Central California ENT" are "AOMT" (1 trials), "Acute Otitis Media" (1 trials), "Bilateral Middle Ear Effusion" (1 trials), "Chronic Sinusitis" (1 trials) and "Chronic Tympanic Membrane Perforation" (1 trials). Many other conditions were trialed in "Central California ENT" in a lesser frequency.

Most popular intervention types in "Central California ENT" are "Drug" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "OTO-201" (2 trials), "ASP0598" (1 trials), "FinESS Sinus Treatment" (1 trials), "Matching Placebo" (1 trials) and "Non Coated Sinus Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central California ENT" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Central California ENT". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Central California ENT, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central California ENT, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".